Global Cell Culture Media for Production Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cell Culture Media for Production Market Research Report 2024
Cell Culture Media are used to provide nutrients for cells growth in research, diagnostic and manufacturing applications. Typical cell culture media contain a mixture of defined nutrients dissolved in a buffered physiological saline solution. In cell culture, media are used to facilitate the growth of cells. Media are water-based liquids that can be provided in liquid or in dry powder format. Dry powder media has to be hydrated with water or with process liquids. Process liquids are water-based buffers and saline solutions which facilitate the cell culture process and ensure that the cell culture environment remains at a constant pH.
According to Mr Accuracy reports new survey, global Cell Culture Media for Production market is projected to reach US$ 2103.2 million in 2029, increasing from US$ 1151 million in 2022, with the CAGR of 8.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cell Culture Media for Production market research.
The Cell Culture Media for Production market is primarily driven by the growing biopharmaceutical and biotechnology industries' demand for efficient and consistent cell culture processes. Cell culture media are essential components in producing biotherapeutics, vaccines, and other biologics on a large scale. The increasing need for biopharmaceutical products, coupled with advancements in cell line development and bioprocess optimization, contributes to market growth. Moreover, the demonstrated impact of well-defined and high-performing media on product yield and quality further propels adoption. However, challenges include formulating complex media for specific cell lines and addressing regulatory compliance in biomanufacturing. Navigating process scalability, minimizing raw material variability, and optimizing production costs are ongoing concerns. The market's success relies on continuous innovation in media formulations, collaborations between biomanufacturers and regulatory bodies, and comprehensive education on the benefits and potential challenges of using cell culture media for large-scale production while addressing the evolving challenges associated with biopharmaceutical production and quality assurance.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cell Culture Media for Production market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher
Merck
Corning
Cytiva
Lonza
Fujifilm
HiMedia Laboratories
Takara
Kohjin Bio
Sartorius
Jianshun Biosicences
OPM Biosciences
Yocon
Avantor
Bio-Rad
Stemcell Technologies
Bio-Techne
Sino Biological
Miltenyi Biotec
Segment by Type
With Serum
Serum-free
Biopharmaceutical Manufacturing
Gene Therapy
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Cell Culture Media for Production report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Cell Culture Media for Production market is projected to reach US$ 2103.2 million in 2029, increasing from US$ 1151 million in 2022, with the CAGR of 8.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cell Culture Media for Production market research.
The Cell Culture Media for Production market is primarily driven by the growing biopharmaceutical and biotechnology industries' demand for efficient and consistent cell culture processes. Cell culture media are essential components in producing biotherapeutics, vaccines, and other biologics on a large scale. The increasing need for biopharmaceutical products, coupled with advancements in cell line development and bioprocess optimization, contributes to market growth. Moreover, the demonstrated impact of well-defined and high-performing media on product yield and quality further propels adoption. However, challenges include formulating complex media for specific cell lines and addressing regulatory compliance in biomanufacturing. Navigating process scalability, minimizing raw material variability, and optimizing production costs are ongoing concerns. The market's success relies on continuous innovation in media formulations, collaborations between biomanufacturers and regulatory bodies, and comprehensive education on the benefits and potential challenges of using cell culture media for large-scale production while addressing the evolving challenges associated with biopharmaceutical production and quality assurance.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cell Culture Media for Production market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher
Merck
Corning
Cytiva
Lonza
Fujifilm
HiMedia Laboratories
Takara
Kohjin Bio
Sartorius
Jianshun Biosicences
OPM Biosciences
Yocon
Avantor
Bio-Rad
Stemcell Technologies
Bio-Techne
Sino Biological
Miltenyi Biotec
Segment by Type
With Serum
Serum-free
Segment by Application
Biopharmaceutical Manufacturing
Gene Therapy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Cell Culture Media for Production report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source